Tiny Gems

Wednesday Aug 03, 2022 - 2:36 pm

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate Its CYB004 Clinical Development Program

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, has completed the acquisition of a phase 1 N,N-Dimethyltryptamine (“N,N-DMT”) study, the largest DMT study to date. The study provides key data relating to the company’s proprietary CYB004 substance with the potential to effectively treat anxiety disorders. “The phase 1 EBRX-101 study, now…

Wednesday Aug 03, 2022 - 1:24 pm

InvestorNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Announces Significant Expansion of Service to PG&E, Utility Company Doubles Number of ASRs under Contract

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, continues to expand its footprint as new clients sign up for the K5 Autonomous Security Robots (“ASRs”) and existing clients add to their contracts. The most recently announced growth comes as the Pacific Gas and Electric Company (“PG&E”), the leading subsidiary of the holding company PG&E Corporation (NYSE: PCG),…

Wednesday Aug 03, 2022 - 10:18 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Adds EV Technology Team Centrally Located to Motor City Resources

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the addition of a new EV Technology team, focusing on developing EV technologies for Mullen’s portfolio of commercial vans. Located in Pontiac, Michigan, and centrally located to all automotive resources the Motor City Area has to offer, the team will be home to a new division of engineers and technology developers focused on…

Tuesday Aug 02, 2022 - 1:50 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology Helping Innovators of Today, Leaders of Tomorrow

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) patented DehydraTECH(TM) has been regarded as one of the most innovative drug delivery technologies in years, proving useful in delivering a wide range of active pharmaceutical ingredients in a more palatable and effective way. Studies have also demonstrated DehydraTECH’s ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances, with cannabinoids by as much as 27x…

Tuesday Aug 02, 2022 - 11:23 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) CEO Spotlighted in Benzinga Live Interview

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, will be the topic of discussion in an upcoming Benzinga YouTube channel interview. The live interview, hosted by Zunaid Sulemanet and slated for Aug. 4, 2022, at 1:30 p.m. ET will feature Mullen CEO and chair David Michery. According to the announcement, Michery’s previous interviews with Benzinga have been some of its most popular events,…

Tuesday Aug 02, 2022 - 11:08 am

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Featured in Bell2Bell Podcast

Aditxt (NASDAQ: ADTX) was featured in the Bell2Bell Podcast, a part of IBN’s (InvestorBrandNetwork) sustained effort to provide specialized content distribution via widespread syndication channels. Amro Albanna, co-founder, chairman and CEO of Aditxt, joined the latest episode to provide an overview of the company and discuss its business model. “We are a biotech innovation company, and our focus is on immune diseases. The reality is…

Tuesday Aug 02, 2022 - 10:53 am

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Enters Joint Venture with Colombia’s Largest Indigenous Tribe

Flora (NASDAQ: FLGC) is a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands. The company today announced a joint venture agreement with Pharma Indigena Misak Manasr Sas (“Manasr”), the largest indigenous tribe in Colombia, on the development of cultivation best practices, manufacturing, export, and marketing of cannabis and cannabis containing products. “We are honored to be given opportunity to work hand-in-hand…

Monday Aug 01, 2022 - 10:35 am

InvestorNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Names Industry Veteran as New COO

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance Micro Motion Technology(RM) (“MMT”) lidar solutions, has appointed Dr. Liqun Han as chief operating officer, a newly created role with responsibilities over the company’s product development and operations team. Han, a proven industry veteran, will continue to be in charge of the company’s flagship ADAS lidar program and will oversee and Cepton’s growing presence…

Monday Aug 01, 2022 - 10:27 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Opens New Automotive EV Development Center in California

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has opened a new 16,000-square-foot automotive development center; the center is located in the center of the technology corridor of Irvine, California, and near the Irvine Spectrum Center. According to the announcement, as the company sees continued growth, it is strategically dividing its automotive teams between the new Irvine location and the existing MULN facility…

Thursday Jul 28, 2022 - 1:07 pm

InvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) Targeting Significant Unmet Medical Need with CycloSam(R)

QSAM Biosciences (OTCQB: QSAM) is a company developing a new class of drugs called radiopharmaceuticals that deliver radiation therapy directly and specifically to cancer cells. The company’s lead drug candidate, CycloSam(R), is a clinical-stage bone-seeking radiopharmaceutical designed to deliver targeted radiation safely and precisely to tumors in the bone. “QSAM is leading the charge to evaluate a new treatment for bone cancer and other related,…

Thursday Jul 28, 2022 - 9:55 am

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO to Participate in Upcoming Canaccord Genuity Growth Conference

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), will be presenting at the 42nd annual Canaccord Genuity Growth Conference; the four-day event is scheduled for Aug. 8–11, 2022, in Boston. During the conference, Cybin CEO Doug Drysdale will present a fireside chat. Drysdale’s presentation is slated for Thursday, Aug. 11, 2022, at 3:30 p.m. ET. Interested individuals are invited…

Wednesday Jul 27, 2022 - 1:29 pm

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Poised with Strong In-Market Brand Portfolio, Cultivation and Export Capabilities

Flora Growth Corp. (NASDAQ: FLGC) recently reported that its board of directors had authorized the repurchase of up to $5 million of its outstanding common shares. “These recent developments highlight Flora management’s confidence in where the company is headed and its potential for growth as the year progresses. It also assures shareholders of the company’s commitment to driving shareholder value and exploring various opportunities to…

Wednesday Jul 27, 2022 - 11:49 am

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD Hypertension Study Completes Dosing with No Serious Adverse Events

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that dosing with its DehydraTECH(TM)-processed cannabidiol (“DehydraTECH-CBD”) has been completed in its multi-week human clinical hypertension study HYPER-H21-4. According to the update, no serious adverse events have been reported as a result of the dosing. “We are extremely pleased that dosing has been completed on time in this multi-week clinical study…

Wednesday Jul 27, 2022 - 9:57 am

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) to Present at J.P. Morgan Auto Conference

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, today announced that its Chief Executive Officer Dr. Jun Pei and Chief Financial Officer Hull Xu will be participating in the J.P. Morgan Auto Conference. Cepton is scheduled to present at the event at 5:15 p.m. ET. on Wednesday, Aug. 10, 2022. Interested parties may visit https://ibn.fm/53L5r to register and view…

Tuesday Jul 26, 2022 - 3:00 pm

InvestorNewsBreaks – Tingo Inc. (TMNA), MICT Inc. (NASDAQ: MICT) File Form S-4 Merger Registration and Joint Proxy Statement

Tingo (OTC: TMNA) and MICT (NASDAQ: MICT) today announced that they have filed a registration and joint proxy statement with the Securities and Exchange Commission (“SEC”) in connection with their anticipated merger. According to the update, the merger is expected to create a >$1.0 billion annualized revenue and highly profitable fintech and agri-fintech company serving the African and Asian markets with a global expansion strategy.…

Tuesday Jul 26, 2022 - 12:26 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Licensee Launches Ko Brand in Preparation to Deploy DehydraTECH CBD Products in Japan

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its exclusive* Japanese licensee, Premier Wellness Science Co. Ltd., officially launched the first generation of its new cannabidiol (“CBD”) products under the brand “Ko.” According to the update, the brand was launched for the Japanese consumer market on July 21, 2022. Premier will create its own e-commerce infrastructure and digital…

Tuesday Jul 26, 2022 - 11:02 am

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) to Release Q2 2022 Results, Host Conference Call and Webcast

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, today announced that it will provide a business update and release its financial results for the second quarter of 2022 following the close of the market on Monday, Aug. 8, 2022. Cepton will also hold a conference call and webcast at 2:30 p.m. PT / 5:30 p.m. ET that same day.…

Tuesday Jul 26, 2022 - 10:11 am

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Samsung Mexico SDS Contract Award

Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process as well as providing a platform for B2B cross-border shipping in the NAFTA region, has been awarded a contract with Samsung Mexico in regard to its SDS business. According to the announcement, FRGT has already started to use its platform to assist with shipments from Mexico to the…

Tuesday Jul 26, 2022 - 9:26 am

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Scheduled Annual Shareholder Meeting

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has scheduled its annual shareholder meeting. The company’s 2022 Annual Meeting of Shareholders will begin at 10 a.m. ET on Aug. 15, 2022; the meeting will be held virtually. According to the announcement, notice of the annual meeting and a proxy statement containing meeting details should be available approximately July 25,…

Monday Jul 25, 2022 - 2:29 pm

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Committed to Becoming Prominent International Player in Lidar Space

Cepton (NASDAQ: CPTN) recently opened a newly renovated office in Metro Detroit (Troy, Michigan). The office is intended to enable the company to continue to forge close relationships with automakers centered around the heart of the U.S. auto industry. “Having a strong presence in Detroit not only enables us to keep up with the latest trend in the industry but also makes us part of…

Monday Jul 25, 2022 - 10:13 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on Phase 2 EB Trial

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today provided an update on its phase 2 clinical trial using investigational drug INM-755 cannabinol (“CBN”) cream for the treatment of patients with epidermolysis bullosa (“EB”). Based on safety data of the first five adult patients who completed the phase 2 study, an independent data monitoring committee agreed it…

Thursday Jul 21, 2022 - 2:58 pm

InvestorNewsBreaks – Golden Matrix Group Inc.’s (NASDAQ: GMGI) GMX-Ag System Facilitating Brand Expansion, Global Market Penetration

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, has been a key beneficiary of a trend that has seen hundreds of gambling platforms opt for white label product offerings from third-party providers. GMGI provides its end customers with access to a substantial portfolio of upwards of 10,000 games. “Golden Matrix Group has looked to cater to growing…

Thursday Jul 21, 2022 - 2:16 pm

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Reminder for Upcoming Annual Shareholder Meeting

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today issued a reminder for its current shareholders regarding the upcoming annual shareholder meeting. Beginning at 9:30 a.m. ET on July 26, 2022, Mullen will conduct a required formal shareholder meeting, which will be followed by a company presentation by David Michery, CEO and chairman of Mullen Automotive. The in-person meeting will be held at…

Wednesday Jul 20, 2022 - 3:02 pm

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Unlocking ‘New Frontiers of Discovery’ with Kernel Flow

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various conditions, has announced preliminary data from a feasibility study using Kernel Flow. The results indicate that ketamine-induced changes in functional connectivity last for several days after administration of the substance. “Kernel Flow is the first easy-to-use, wearable device that collects and measures real-time brain activity before, during…

Wednesday Jul 20, 2022 - 2:42 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Expanding Patient Eligibility in Potentially Pivotal Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP) recently announced that its global clinical trial for a potentially pivotal brain cancer treatment will expand patient eligibility following an amendment to its protocol for the study. “CNS has been enrolling patients in its phase II clinical trial for novel drug candidate Berubicin, which has shown promise in fighting the aggressive brain cancer glioblastoma (‘GBM’),” explains a recent article. “The trial…

Tuesday Jul 19, 2022 - 1:16 pm

InvestorNewsBreaks – Why Freight Technologies Inc. (NASDAQ: FRGT) Is ‘One to Watch’

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process. The company is on a mission to revolutionize cross-border shipping by providing carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity. A recent article reads: “Fr8Tech leverages artificial intelligence to provide cloud-based platforms aimed at automating the over-the-road (‘OTR’) transportation process, effectively reducing…

Monday Jul 18, 2022 - 1:29 pm

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Poised for First-Mover Advantage

Flora Growth Corp. (NASDAQ: FLGC) is aggressively pushing its brand and advancing the conversation around cannabis. “In addition, with its able management, Flora is recognizing and capitalizing on opportunities that others are yet to identify, placing it in a unique position that not only gives it a first-mover advantage but also presents a unique opportunity for growth,” a recent article that discusses a research report…

Monday Jul 18, 2022 - 12:51 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Partners to Propel New, Exciting Growth Opportunities

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently entered into agreements with beverage developer BevNology. “The BevNology collaboration not only includes a commercial license agreement for products with active ingredients derived from hemp under BevNology’s brand but also a manufacturing operating agreement utilizing BevNology’s new, custom-built state-of-the-art processing facility outside Atlanta…. The manufacturing agreement will help Lexaria broaden its production…

Monday Jul 18, 2022 - 10:05 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Appoints Michael Woudenberg as Chief Operating Officer

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced its appointment of Michael Woudenberg as chief operating officer of the company, overseeing all day-to-day operations. Woudenberg previously served as senior vice president of chemistry, manufacturing and controls. For the past several years, he has been an integral part of InMed’s executive team, supporting multiple functions within…

Friday Jul 15, 2022 - 12:38 pm

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Working to Make Lidar a Standard Feature of Today’s Cars, Key Component of Future Autonomous Vehicles

Cepton (NASDAQ: CPTN) is an innovator and leader specializing in high-performance Micro Motion Technology (“MMT(R)”) lidar solutions that enable reliable, scalable, long-range, high-resolution 3D perception for smart applications. The company was recently added to the Russell 3000(R) Index, effective June 27, 2022, following its rapid growth over the last year. According to co-founder and CEO Dr. Jun Pei, the inclusion in the Russell 3000(R) Index…

Thursday Jul 14, 2022 - 2:00 pm

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Equipping Physicians, Individuals with Comprehensive Immune System Views

Aditxt (NASDAQ: ADTX) provides the AditxtScore(TM), a proprietary immune mapping technology designed to provide a personalized profile of the immune system. “Licensed from Stanford University, AditxtScore(TM) for COVID-19 is Aditxt’s first commercial product. It enables patients to know the level of protection that an immune response to the SARS-CoV-2 virus or vaccination confers them…The results may also influence the vaccine-hesitant populace to take the vaccine,…

Wednesday Jul 13, 2022 - 3:12 pm

InvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) Expands IP Estate with Receipt of Third US Patent for CycloSam(R)

QSAM Biosciences (OTCQB: QSAM) is a company developing next-generation targeted therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (“CycloSam(R)”), for the treatment of cancer and related diseases. The company today announced that the United States Patent & Trademark Office has granted a key patent protecting how CycloSam(R) is formulated and prepared, namely by using a nonradioactive kit that can be delivered and stored local to the administration site and…

Wednesday Jul 13, 2022 - 12:39 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Nearing Start Date for Its Human Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the pending start of its upcoming human nicotine study NIC-H22-1. Through the study, Lexaria expects to evidence that processing purified nicotine with its patented drug delivery technology, DehydraTECH(TM), leads to enhanced oral-tissue absorption and reduced negative experiences. NIC-H22-1, a minimum 36-person human pharmacokinetic (“PK”) randomized, double blinded, cross-over study, will compare…

Tuesday Jul 12, 2022 - 1:04 pm

InvestorNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) CYB003 Phase 1/2a Clinical Trial Through Clinilabs Begins Enrollment

Clinilabs Drug Development Corporation, a global, full-service contract research organization with deep expertise in central nervous system drug development, today announced commencement of enrollment in a phase 1/2a clinical trial of CYB003. Being developed by Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” CYB003 is the first novel psilocybin analog to be evaluated in phase 1/2a…

Tuesday Jul 12, 2022 - 10:00 am

InvestorNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Milestone Agreement with DPL Featured in NGT News Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, recently signed a binding agreement with DelPack Logistics LLC (“DPL”), an Amazon delivery service partner, for DPL to purchase up to 600 Mullen Class 2 EV cargo vans over a period of 18 months. The vans will be fully homologated for the United States, of which the first 300 can be delivered by Nov. 30,…

Tuesday Jul 12, 2022 - 9:48 am

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Upgrades EDI to Include Location Sharing, Shipment Status Improvements

Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process and providing a platform for B2B cross-border shipping in the NAFTA region, announced that it has upgraded its electronic data interchange (“EDI”). The upgraded EDI now features the ability to enable location sharing and shipment status changes. “To help increase Fr8App large shippers’ efficiency and the stickiness of…

Monday Jul 11, 2022 - 2:05 pm

InvestorNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Secures New Contract from Large Real Estate Investment Trust (REIT)

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, announced its receipt of another new contract for autonomous security robot (ASR) services. The announcement reads, “One of the largest U.S. real estate investment trusts (REIT) signed an agreement for Knightscope’s K5 ASR to patrol one of its open-air, mixed-use shopping centers in southern Florida. As of 2022, the…

Monday Jul 11, 2022 - 10:30 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Enters Agreement Putting Cargo Van Program ‘Front and Center for Last Mile Delivery Opportunities’

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its entry into a binding agreement with DelPack Logistics LLC (“DPL”), an Amazon Delivery Service Partner, for DPL to purchase up to 600 Mullen Class 2 EV cargo vans over the next 18 months. The vans will be fully homologated for the United States and equipped with all airbags as required by U.S.…

Monday Jul 11, 2022 - 10:01 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study Expected to Accelerate Clinical Development Path of CYB004

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that, through its wholly-owned subsidiary Cybin IRL Limited, it has completed the acquisition of a phase 1 N,N-dimethyltryptamine (“DMT”) study from Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1). The DMT study, which is the largest to date, is expected to accelerate the clinical development path of…

Friday Jul 08, 2022 - 2:45 pm

InvestorNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Achieves 221% YoY Quarterly Revenue Growth

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, recently reported financial results for its second fiscal quarter, with quarterly revenues rising by 221% year-over-year to $8,482,743. “Meanwhile, Q2 net income rose to $586,984, a significant increase relative to the $127,986 recorded in the equivalent period a year ago. Golden Matrix Group attributed part of the significant increase…

InvestorNewsBreaks

NewsBreak Category: Tiny Gems

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions